Results

Total Results: 1,225 records

Showing results for "group".

121. Archived: Evidence Summary: Screening for Multifactorial Dyslipidemia: Lipid Disorders in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening-july-2016
     August 09, 2016 - Between-group differences dissipated by year 5. … group. … DISC Collaborative Research Group. … Writing Group for the DISC Collaborative Research Group. … Obarzanek E, Kimm SY, Barton BA, et al; DISC Collaborative Research Group.

122. Evidence Summary: Latent Tuberculosis Infection in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
     May 02, 2023 - After 5 years of follow-up, 76 participants (1.1%) in the 12-week group, 34 (0.5%) in the 24-week group … , 24 (0.3%) in the 52-week group, and 97 (1.4%) in the placebo group developed active tuberculosis (eTable … , 0.35 (95% CI, 0.24-0.52) in the 24-week group, and 0.25 (95% CI, 0.16-0.39) in the 52-week group. … and reported all-cause mortality with 0 deaths in the rifampin group and 1 in the isoniazid group. … , 0.0% for the 24-week treatment group, and 0.01% for the 52-week treatment group.

123. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
     July 01, 2008 - Patients in either group who developed symptomatic urinary infections were also treated with the study … The placebo group was no more likely than the treatment group to have a symptomatic urinary tract infection … Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group. … Manitoba Diabetes Uri- nary Tract Infection Study Group.

124. Archived: Evidence Summary: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary11/asymptomatic-bacteriuria-in-adults-screening-2008
     July 15, 2008 - Patients in either group who developed symptomatic urinary infections were also treated with the study … The placebo group was no more likely than the treatment group to have a symptomatic urinary tract infection … Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group. … Manitoba Diabetes Urinary Tract Infection Study Group.

125. Archived: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening-2014
     June 23, 2014 - AAA in men ages 65 to 75 years who have never smoked rather than routinely screening all men in this group … In the largest trial, where prevalence of AAA was approximately 5% in the screened group, screening was … group) or 1.4 fewer AAA-related deaths per 1,000 men screened 3 . … Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. … [PMID: 9853436] Cao P, De Rango P, Verzini F, Parlani G, Romano L, Cieri E; CAESAR Trial Group.

126. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zHvENvrSUeZh6gFPUK_37c
     February 13, 2018 - Women randomized to the control group received no screening. … and 2 intervention groups (0.35% in the control group, 0.32% in the transvaginal ultrasound group, and … 0.32% in the CA-125 ROCA group). … group, and 3.17% of participants in the PLCO CA-125 plus ultrasound group.3 Up to 15% of these women … US Cancer Statistics Working Group.

127. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - The Canadian Cooperative Study Group. … The DAMAD Study Group. … The SALT Collaborative Group. … the control group for cancer mortality. … versus the control group for CRC incidence.

128. Ericka Gibson, M.D., M.P.H. | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/ericka-gibson-md-mph
     January 01, 2025 - M.D., M.P.H., is a board-certified obstetrician-gynecologist with the Southeast Permanente Medical Group … Gibson leads the Perinatal Patient Safety team at the Southeast Permanente Medical Group, establishing

129. Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/7eLc5kBtomL_HKpYDwsFPf
     July 01, 2009 - Eye Diseases Prevalence Research Group. … Eye Diseases Prevalence Research Group. … Clin- ical Trial Group. … (Cochrane Eyes and Vision Group).mp. … (Cochrane Eyes and Vision Group).mp.

130. Archived: Evidence Summary: Abdominal Aortic Aneurysm: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary8/abdominal-aortic-aneurysm-screening-2014
     January 15, 2014 - Less than 1% of the control group crossed over in any trial to receive elective surgery, even at the … compared with the control group. … for all periods up to 10-year follow-up compared with the control group. … Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. … ; IG = intervention group; MASS = Multicentre Aneurysm Screening Study; NR = not reported

131. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
     June 20, 2017 - −0.15 (−0.16 in the intervention group vs −0.01 in the control group). 36 In terms of absolute change … However, group differences were attenuated at longer-term follow-up in the other 2 trials. … Wilson DM, Abrams SH, Aye T, et al; Glaser Pediatric Research Network Obesity Study Group. … Comparative effectiveness: Study did not have a control group. … No group differences on eating disorder pathology or body dissatisfaction.

132. Archived: Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - The trial reported no cases of NTDs in the experimental group and 6 cases in the control group (0% vs … Group. … : 46 Informative pregnancies in exposed group: 2421 Multiple pregnancy cases in control group: 32 … : 19 Informative pregnancies in exposed group: 141 Multiple pregnancy cases in control group: 12 … cases in comparison group: 543 Comparison group: 2000 OR, 1.04 (0.91-1.18) Crider et

133. S5Tzxonejd3Qzsoj-7Bq5P (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/s5tZxonEjD3qZsoj-7Bq5P
     May 01, 2014 - use than those in the control group (P � 0.024). … those in the control group at 6 months (P � 0.045). … reported less depressed mood than those in the control group after 6 mo. … In addition, we have concerns with this group of computer- based studies that involved the same group … Table 2—Continued Primary Outcome Measure Follow-up Intervention Group Control Group Effect Size P Value

134. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholerolemia: Evidence Report and Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
     August 09, 2016 - Corresponding Author: Paula Lozano, MD, MPH, Group Health Research Institute, 1730 Minor Ave, Ste 1600 … Included intervention trials had to compare an inter- vention against a usual care or control group. … Scientific Steering Committee on behalf of the Simon Broome Register Group. … Scientific Steering Committee on behalf of the Simon Broome Register Group. … Braamskamp MJ, Stefanutti C, Langslet G, et al; PASCAL Study Group.

135. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
     January 15, 2002 - ischemic strokes in the intervention group and 21 in the "no aspirin" group. 9 Despite the uncertainty … Steering Committee of the Physicians' Health Study Research Group. … HOT Study Group. Lancet 1998;351(9118):1755-62. 9. … London: BMJ Publishing Group; 2001. 26. … Control Group Aspirin Group Control Group BMD 5 Self-reported peptic ulcer disease 2.6%

136. Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
     January 01, 2002 - strokes in the intervention group and 21 in the “no aspirin” group.9 Despite the uncertainty of stroke … group group group BMD5 Self-reported peptic 2.6% 1.6% <0.05 1.7 3 3 ulcer disease PHS4 Upper gastrointestinal … Steering Committee of the Physicians’ Health Study Research Group. … HOT Study Group. Lancet. 1998;351(9118):1755-1762. 9. … London: BMJ Publishing Group; 2001. 26.

137. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening, July 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-2005
     July 12, 2005 - Group vs. Indiv. … ); 25.5 kg/m 2 (conventional treatment group);  25.1 kg/m 2 (control group) D,E no … by sex; p < 0.001, boys in combined group vs. girls in combined group p < 0.05, boys in combined … group vs. girls in increased PA group none Fair Combined increased PA + decreased SB  girls … Diagnostic testing procedures applied equally to each group.

138. Archived: Final Evidence Review: Asymptomatic Bacteriuria in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review11/asymptomatic-bacteriuria-in-adults-screening-2008
     July 15, 2008 - Patients in either group who developed symptomatic urinary infections were also treated with the study … The placebo group was no more likely than the treatment group to have a symptomatic urinary tract infection … Patients in the placebo group averaged 34 days of antibiotic use per 1000 days of follow-up, compared … with 158 days of antibiotic use per 1000 days of follow-up in the treatment group. … Manitoba Diabetes Urinary Tract Infection Study Group.

139. Archived: Evidence Summary: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/falls-prevention-in-older-adults-interventions-2018
     April 17, 2018 - Because age and other individual and environmental factors determine risk of fall, control group fall … and control group). … Ferrer A, Formiga F, Sanz H, de Vries OJ, Badia T, Pujol R; OCTABAIX Study Group. … Pérula LA, Varas-Fabra F, Rodríguez V, et al; EPICA Study Collaborative Group. … Heterogeneous group of interventions.

140. 4Z Bygyyfkv5Uru6Fjx8Pb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/4z_ByGyYfKV5uRU6fjx8pB
     March 01, 2014 - Carpenter and Coustan, the American Diabetes Associa- tion (2000–2010), the National Diabetes Data Group … The Mild GDM Trial reported 7 prenatal visits in the treat- ment group versus 5 in the control group … compared with the control group (1, 9, 10). … compared with the nontreatment group (RR, 0.63 [CI, 0.55 to 0.72]; n � 1665). … Grossman, MD, MPH (Group Health Cooperative, Seattle, Washington); Jessica Herz- stein, MD, MPH (Air